ADMA Biologics amends bylaws to reduce director removal threshold to majority vote and add exclusive forum provisions

ADMA BIOLOGICS, INC.

Reduced director removal with cause threshold from 66 2/3% to a majority of voting holders.
Added exclusive forum provision requiring internal corporate suits be brought in Delaware courts.
Added federal forum selection clause for Securities Act claims unless company consents otherwise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.